Next Article in Journal
Photodynamic Therapy Using Talaporfin Sodium for Local Failure after Chemoradiotherapy or Radiotherapy for Esophageal Cancer: A Single Center Experience
Next Article in Special Issue
Strategies to Improve Participation of Older Adults in Cancer Research
Previous Article in Journal
Effects of Steam Sterilization on 3D Printed Biocompatible Resin Materials for Surgical Guides—An Accuracy Assessment Study
Open AccessArticle

Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices

1
Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91107, USA
2
University of California San Francisco School of Medicine, San Francisco, CA 94143, USA
3
Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Corona, CA 92879, USA
4
Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, South Pasadena, CA 91030, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(5), 1508; https://doi.org/10.3390/jcm9051508
Received: 29 April 2020 / Revised: 13 May 2020 / Accepted: 14 May 2020 / Published: 17 May 2020
The treatment of metastatic renal cell carcinoma (mRCC) has rapidly evolved; however, the progress made in the field is heavily contingent upon timely and efficient accrual to clinical trials. While a substantial proportion of accrual occurs at tertiary care centers, community sites are playing an increasing role in patient recruitment. In this article, we discuss strategies to optimize collaborations between academic and community sites to facilitate clinical research. Further, as the role of biomarker discovery has become increasingly important in tailoring therapy, we will discuss opportunities to bridge diverse accrual sites for the purpose of translational research. View Full-Text
Keywords: renal cell carcinoma; team medicine; translational research; community practice; clinical trials renal cell carcinoma; team medicine; translational research; community practice; clinical trials
Show Figures

Figure 1

MDPI and ACS Style

Salgia, N.J.; Philip, E.J.; Ziari, M.; Yap, K.; Pal, S.K. Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices. J. Clin. Med. 2020, 9, 1508.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop